|Mr. Erez Raphael||CEO & Director||665.86k||N/A||1973|
|Mr. Richard A. Anderson||Pres & GM of North America||430.59k||N/A||1969|
|Mr. Zvi Ben David||CFO, Treasurer & Sec.||170.65k||N/A||1961|
|Mr. Dror Bacher||Chief Operating Officer||248.63k||N/A||1975|
|Dov Oppenheim||Co-Founder & Production Chief||N/A||N/A||N/A|
|Claudia Levi||Content & Communications Mang.||N/A||N/A||N/A|
|Ms. Suzanne Bedell||VP of Marketing||N/A||N/A||N/A|
|Mr. Olivier R. Jarry||Sr. VP of Strategy & Bus. Devel.||N/A||N/A||1961|
|Mr. Jean Christophe Muyl||Head of Commercialization North America||N/A||N/A||N/A|
|Yinon Amir||Head of Software Innovation||N/A||N/A||N/A|
DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Tools, which are devices that integrate with applications on a user's smartphone; DarioEngage, a population health management platform; and the Dario Loop, an AI-driven journey engine. It also sells device-specific disposables test strip cartridges, lancets, and Dario Blood Glucose Monitoring System; and Dario Smart Diabetes Management Solution, which includes tools to help diabetic patients manage their disease. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is based in New York, New York.
DarioHealth Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.